Status:

UNKNOWN

Pathophysiologic Mechanism for MYOcarditis in COVID19 VAccinations ("MYOVAx" Study)

Lead Sponsor:

National Heart Centre Singapore

Collaborating Sponsors:

KK Women's and Children's Hospital

Changi General Hospital

Conditions:

Myocarditis

Eligibility:

All Genders

5-99 years

Brief Summary

The coronavirus disease 2019 (COVID-19) is an ongoing pandemic which has infected more than 160 million people and caused 3.4 million deaths worldwide till May 2021. With the recent rollout of COVID-1...

Detailed Description

This is a prospective cohort study of patients with confirmed COVID19 vaccine associated myocarditis (CVAM). Patients will be required to fulfil CDC criteria for probable myocarditis with an enriched ...

Eligibility Criteria

Inclusion

  • All patients age admitted to inpatient wards of public hospitals with cardiovascular complaints of chest pain, breathlessness, and/or palpitations, who have prior COVID19 vaccination within 21 days and who meet probable or confirmed criteria for myocarditis according to CDC (Annex A).
  • All patients age presented to outpatient clinics of public hospitals with complaints of chest pain, breathlessness, and/or palpitations accompanied with rise of cardiac Troponin biomarker, who have prior COVID19 vaccination within 30 days and who meet probable or confirmed criteria for myocarditis according to CDC (Annex A).
  • Age \>/= 5. Patients under age 21 will need parental consent.
  • Willing to adhere to study protocol and other study requirements
  • Provide informed consent
  • Women who are pregnant or are breastfeeding may be included but will not be offered cardiac MRI with contrast, for safety reasons.

Exclusion

  • Known prior abnormal heart function
  • Contraindication to cardiac MRI
  • Any condition which the investigator believes will prevent adherence to study protocol

Key Trial Info

Start Date :

November 1 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2023

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT05282498

Start Date

November 1 2021

End Date

December 31 2023

Last Update

April 13 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

National Heart Centre Singapore

Singapore, Singapore, 169609